SpaceX shares rose 9.5% following its earnings call, but longtime technology analyst Gene Munster argued that the stock warranted a gain of more than 30%. His bullish assessment centered on the gap between Elon Musk’s revenue outlook and Wall Street’s estimates.

Key Takeaways

  • SpaceX shares gained 9.5%, below the more-than-30% rise Munster argued was warranted.
  • Munster cited Musk’s outlook for $500 billion to $1 trillion in annual recurring revenue by the end of next year.
  • Some analysts raised fourth-quarter 2027 revenue estimates to $70 billion from a previous $31 billion expectation.

Table of Contents

SpaceX shares rally, but Munster sees a larger move

Munster’s assessment followed SpaceX’s earnings call the previous night. He argued that Wall Street routinely discounts Musk’s projections, describing analysts as taking the low end of Musk’s guidance and then cutting it by another 50%.

The stock’s reported 9.5% advance was substantial, though well short of the move Munster advocated. His call for a gain above 30% was an analyst opinion, not a reported market outcome.

Revenue revisions remain below Musk’s outlook

According to Munster’s account of the call, Musk said SpaceX should reach annual recurring revenue of $500 billion to $1 trillion by the end of next year.

Separately, Munster said Wall Street had previously expected fourth-quarter 2027 revenue of $31 billion. Analysts who had already adjusted their forecasts after the results raised that estimate to $70 billion. The quarterly estimates and Musk’s annual recurring revenue outlook refer to different measures.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.